Page 2 - MassARRAY Cancer Research in Taiwan
P. 2

1



              Contents









                 All-in-one system for genetic research ......................................................... 2



                 MassARRAY Cancer Research in Taiwan...................................................... 3


                       ERCC5 and ERCC1 polymorphisms associated with the survival of male patients with OSCC

                        treated with adjuvant concurrent chemoradiotherapy ............................................................ 3

                       A simple and highly specific DNA Assay to prioritize follow-up decisions in fecal

                        immunochemical test-positive individuals ............................................................................... 4

                       Polymorphisms of mismatch repair pathway genes predict clinical outcomes in OSCC
                        patients receiving adjuvant concurrent chemoradiotherapy ................................................... 5

                       Comparative analysis of two methods for the detection of EGFR Mutations in plasma

                        circulating tumor DNA from lung adenocarcinoma patients .................................................... 6

                       Combined microsatellite instability and EMAST might be a more promising immune

                        biomarker in colorectal cancer ................................................................................................. 7

                       Thrombotic Hemangioma with Organizing Features: Expanding the Spectrum of

                        GNA-mutated Hemangiomas with a Predilection for the Skin of the Lower Abdominal
                        Regions. ..................................................................................................................................... 8

                       High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a

                        histopathological and molecular study of 85 cases indicating GNA14 as the most commonly

                        mutated gene   .......................................................................................................................... 9

                       GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing

                        hemangioma   .........................................................................................................................10


                 Customized panels   ............................................................................................................. 11



                 MassARRAY Cancer Panels ......................................................................................... 11


                 PIK3CA/Lung cancer/Colon cancer/AllRAS Panels






       FCBiotech             A choice to have your life for the best, FCB!
   1   2   3   4   5   6   7